logo
Laurus Labs Ltd.
20 May 2025
861.20
1.40%
AUM Capital
Laurus Labs Ltd (Laurus) was incorporated in the year 2005 as an Anti-Retroviral (ARV) Active Pharmaceutical Ingredient (API) company. (ARV drugs are medications used to treat HIV infection and prevent its progression). Later, it diversified its operations by entering into Formulations and Contract Development Manufacturing Operations (CDMO) services to become an integrated pharma company. Currently, Laurus's...
Laurus Labs Ltd. is trading above all available SMAs
More from Laurus Labs Ltd.
Recommended